Bavituximab (PGN-401)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 14:40, 26 April 2023 by Warner-admin (talk | contribs) (Text replacement - "2 PubMed]" to "2/ PubMed]")
Jump to navigation Jump to search

Mechanism of action

Binds to phosphatidylserine, provoking an immune response.

Preliminary data

Non-small cell lung cancer

  1. Digumarti R, Bapsy PP, Suresh AV, Bhattacharyya GS, Dasappa L, Shan JS, Gerber DE. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 2014 Nov;86(2):231-6. Epub 2014 Aug 24. link to original article PubMed

Also known as

  • Code name: PGN401
  • Brand name: Tarvacin
Retrieved from "https://hemonc.org/w/index.php?title=Bavituximab_(PGN-401)&oldid=68635"